FOMAT Medical Research has earned the prestigious 2024 Excellence in Patient Centricity Award from the Society for Clinical Research Sites (SCRS). Sponsored by Sanofi, this award recognizes clinical research sites that put patient experience at the heart of their operations. FOMAT’s innovative use of technology to enhance patient engagement and recruitment stood out, showcasing their commitment to making the clinical trial process more accessible, inclusive, and patient-centered.
Leading the Way with AI-Powered Patient Engagement
FOMAT’s approach to patient-centricity revolves around using artificial intelligence (AI) tools that make clinical trials more engaging and supportive for participants. One of the key elements of their success is their AI-driven virtual assistant, “Lucy.” Lucy helps ensure that all patient inquiries are promptly addressed, providing participants with a seamless experience from their very first contact. The virtual assistant’s ability to respond immediately to inquiries reinforces the sense of being heard and valued, a core element of FOMAT’s patient-centric approach.
In addition to Lucy, FOMAT has integrated AI-powered voiceovers in their social media outreach. These voiceovers simplify complex clinical trial information, making it easier for a broader range of patients to understand and engage with. By making information more accessible, FOMAT ensures that diverse patient populations feel included and informed about their options. This approach has helped them reach patients from various backgrounds, who might not typically participate in clinical trials.
A Reflection of Dedication to Patient-Centric Innovation
Upon accepting the award, Nicholas Focil, CEO of FOMAT Medical Research, expressed his gratitude and pride in the recognition from SCRS. “We are honored to be recognized by SCRS and even more so for their Excellence in Patient Centricity Award,” Focil stated. “This award and what it stands for, is the highest honor for us here at FOMAT. It reflects our team’s unwavering dedication to always putting patients front and center. We believe that innovation and technology are key to addressing the evolving needs of our patients and providing them with the best possible care throughout their research journey.”
For FOMAT, the award is not just an acknowledgment of past achievements but a validation of their ongoing mission to innovate in ways that improve the clinical trial experience for participants. Focil emphasized that their use of AI and other digital tools is all about making patients feel respected and valued throughout their clinical trial journey. By focusing on patient needs, FOMAT aims to set new standards in patient-centric research.
Industry Leaders Applaud FOMAT’s Commitment
Jimmy Bechtel, SCRS Vice President of Site Engagement, praised FOMAT’s approach, stating, “The Excellence in Patient Centricity Award celebrates those sites that put patients first, and FOMAT Medical Research’s innovative approach to patient-centricity is truly exceptional. Their use of AI to bridge the gap between patients and research sites sets a new standard in the industry. SCRS applauds their commitment to improving the clinical trial experience and ensuring that patients are engaged, respected, and prioritized at every step.”
Vicky DiBiaso, Head of Patient Informed Development & Health Value Translation at Sanofi, echoed Bechtel’s sentiments. She highlighted the importance of trial sites like FOMAT in advancing patient care and clinical research. “Sanofi is proud to sponsor the 4th annual SCRS Excellence in Patient Centricity Award. We deeply appreciate the contributions that all trial sites make toward medical advancements. Through this award, we are honored to celebrate FOMAT’s digital innovations, which make clinical research an accessible and positive experience for both patient and caregiver communities,” DiBiaso said.
FOMAT’s Role in Enhancing the Clinical Trial Experience
FOMAT’s approach to patient-centricity goes beyond AI tools. The organization has consistently sought to create an inclusive environment where patients from diverse backgrounds can participate in clinical research. Their focus on diversity is a key component of their operations, ensuring that all participants feel represented and valued.
The Excellence in Patient Centricity Award reflects FOMAT’s dedication to creating a patient-first culture. Through AI and other digital innovations, they strive to simplify clinical trial processes and make them more approachable for all. This commitment has helped FOMAT build a strong reputation as a leader in patient-centric clinical research.
Recognizing the Impact of Patient-Centered Innovation
FOMAT Medical Research was one of four finalists for the 2024 Excellence in Patient Centricity Award, alongside EMS Healthcare, IMA Clinical Research, and Velocity Clinical Research. The recognition from SCRS sets FOMAT apart as a trailblazer in the clinical research industry, particularly in the use of technology to improve patient experience.
As they continue to expand their capabilities and explore new ways to serve patients, FOMAT remains committed to using innovation as a means of putting patients first. By doing so, they are helping to shape the future of clinical research and ensuring that patients are always at the heart of the process.
Curious to learn more about FOMAT’s patient-centric approach? Read the full press release here to explore how FOMAT Medical Research is setting new standards in patient care through clinical research.